Returns On Capital Are Showing Encouraging Signs At Ypsomed Holding (VTX:YPSN)
Dec 23
Have your own idea? Try our Stock Screener
Swiss (SMI) Healthcare Sector Analysis
UpdatedDec 25, 2024
DataAggregated Company Financials
Companies35
- 7D-1.6%
- 3M-7.6%
- 1Y5.6%
- YTD4.9%
Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by a pullback from Roche Holding of 2.6%. In the past year, the industry has gained 5.6%. As for the next few years, earnings are expected to grow by 14% per annum.
Sector Valuation and Performance
Has the Swiss Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 25 Dec 2024 | CHF 562.0b | CHF 152.3b | CHF 24.5b | 28.4x | 23x | 3.7x |
| Fri, 22 Nov 2024 | CHF 568.4b | CHF 151.3b | CHF 24.3b | 29.3x | 23.4x | 3.8x |
| Sun, 20 Oct 2024 | CHF 618.7b | CHF 148.5b | CHF 22.6b | 31.2x | 27.4x | 4.2x |
| Tue, 17 Sep 2024 | CHF 603.6b | CHF 147.0b | CHF 22.3b | 32.6x | 27.1x | 4.1x |
| Thu, 15 Aug 2024 | CHF 614.7b | CHF 148.1b | CHF 22.3b | 31.8x | 27.6x | 4.2x |
| Sat, 13 Jul 2024 | CHF 595.8b | CHF 148.7b | CHF 22.7b | 37.8x | 26.3x | 4x |
| Mon, 10 Jun 2024 | CHF 572.5b | CHF 148.9b | CHF 22.7b | 35.4x | 25.2x | 3.8x |
| Wed, 08 May 2024 | CHF 537.2b | CHF 145.9b | CHF 22.8b | 32.7x | 23.5x | 3.7x |
| Fri, 05 Apr 2024 | CHF 553.0b | CHF 144.4b | CHF 22.2b | 35.7x | 24.9x | 3.8x |
| Sun, 03 Mar 2024 | CHF 531.8b | CHF 143.2b | CHF 22.7b | 36.4x | 23.5x | 3.7x |
| Tue, 30 Jan 2024 | CHF 546.6b | CHF 152.0b | CHF 21.9b | 28x | 25x | 3.6x |
| Thu, 28 Dec 2023 | CHF 520.3b | CHF 150.6b | CHF 21.7b | 26.2x | 24x | 3.5x |
| Sat, 25 Nov 2023 | CHF 516.0b | CHF 153.6b | CHF 22.0b | 24.8x | 23.4x | 3.4x |
| Mon, 23 Oct 2023 | CHF 505.6b | CHF 153.2b | CHF 21.6b | 25.7x | 23.4x | 3.3x |
| Wed, 20 Sep 2023 | CHF 539.7b | CHF 145.0b | CHF 21.1b | 32.6x | 25.6x | 3.7x |
| Fri, 18 Aug 2023 | CHF 542.4b | CHF 143.9b | CHF 21.1b | 31.1x | 25.7x | 3.8x |
| Sun, 16 Jul 2023 | CHF 553.9b | CHF 145.1b | CHF 22.0b | 36.1x | 25.2x | 3.8x |
| Tue, 13 Jun 2023 | CHF 574.3b | CHF 148.0b | CHF 22.3b | 34.3x | 25.7x | 3.9x |
| Thu, 11 May 2023 | CHF 579.7b | CHF 146.9b | CHF 22.3b | 32.7x | 26x | 3.9x |
| Sat, 08 Apr 2023 | CHF 574.6b | CHF 147.3b | CHF 22.4b | 33.1x | 25.6x | 3.9x |
| Mon, 06 Mar 2023 | CHF 541.3b | CHF 148.8b | CHF 22.6b | 31.7x | 24x | 3.6x |
| Wed, 01 Feb 2023 | CHF 576.0b | CHF 149.5b | CHF 38.6b | 31.3x | 14.9x | 3.9x |
| Fri, 30 Dec 2022 | CHF 562.7b | CHF 148.4b | CHF 38.0b | 30.1x | 14.8x | 3.8x |
| Sun, 27 Nov 2022 | CHF 580.5b | CHF 149.8b | CHF 38.5b | 34.4x | 15.1x | 3.9x |
| Tue, 25 Oct 2022 | CHF 569.2b | CHF 153.5b | CHF 40.9b | 26.2x | 13.9x | 3.7x |
| Thu, 22 Sep 2022 | CHF 557.5b | CHF 151.1b | CHF 39.9b | 29.5x | 14x | 3.7x |
| Sat, 20 Aug 2022 | CHF 594.6b | CHF 150.2b | CHF 39.7b | 30.6x | 15x | 4x |
| Mon, 18 Jul 2022 | CHF 608.3b | CHF 149.7b | CHF 40.7b | 33.2x | 14.9x | 4.1x |
| Wed, 15 Jun 2022 | CHF 570.5b | CHF 151.1b | CHF 41.3b | 29.6x | 13.8x | 3.8x |
| Fri, 13 May 2022 | CHF 606.9b | CHF 150.1b | CHF 40.9b | 34.1x | 14.8x | 4x |
| Sun, 10 Apr 2022 | CHF 696.1b | CHF 146.0b | CHF 39.2b | 39.9x | 17.7x | 4.8x |
| Tue, 08 Mar 2022 | CHF 612.6b | CHF 145.0b | CHF 39.0b | 31.7x | 15.7x | 4.2x |
| Thu, 03 Feb 2022 | CHF 648.0b | CHF 139.7b | CHF 25.3b | 46.4x | 25.6x | 4.6x |
| Sat, 01 Jan 2022 | CHF 695.7b | CHF 138.7b | CHF 25.1b | 48.6x | 27.7x | 5x |
Price to Earnings Ratio
27.7x
Current Industry PE
- Investors are relatively neutral on the Swiss Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 21.8x.
- The industry is trading close to its 3-year average PS ratio of 3.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 3.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare sector?
| CH Market | -1.77% | |
| Healthcare | -1.59% | |
| Biotech | 0.85% | |
| Healthcare Services | -0.073% | |
| Medical Equipment | -1.48% | |
| Pharma | -1.59% | |
| Life Sciences | -2.01% | |
| Healthtech | -2.33% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 46.4x.
- Analysts are expecting annual earnings growth of 22.3%, which is higher than its past year's earnings growth of 4.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 22% over the next 5 years.
- This is better than its past earnings growth rate of 4.3% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 5.3% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GALD Galderma Group | CHF 98.35 | 3.6% +CHF 810.1m | n/a | PS6x | |
| SKAN SKAN Group | CHF 76.40 | 7.2% +CHF 114.7m | -6.0% | PE53.3x | |
| ALC Alcon | CHF 76.46 | 0.2% +CHF 69.2m | 15.7% | PE36.2x | |
| COPN Cosmo Pharmaceuticals | CHF 61.20 | 2.5% +CHF 24.1m | 18.1% | PE15.1x | |
| SANN Santhera Pharmaceuticals Holding | CHF 11.44 | 18.9% +CHF 22.0m | 13.9% | PE2.2x |
